About Immunodeficiency by defective expression of MHC class I
Immunodeficiency by defective expression of MHC class I is a rare disease catalogued by Orphanet (ORPHA:34592). It is associated with the TAP2, TAP1, TAPBP genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Immunodeficiency by defective expression of MHC class I trials.
Search ClinicalTrials.gov for "Immunodeficiency by defective expression of MHC class I" or filter by Orphanet code ORPHA:34592 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Immunodeficiency by defective expression of MHC class I trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Immunodeficiency by defective expression of MHC class I. Updated daily.